Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-27T01:21:26.805Z Has data issue: false hasContentIssue false
  • English
  • Français

Psychotropic medication in learning disabilities: audit as an alternative to legislation

Published online by Cambridge University Press:  02 January 2018

H. E. J. Miller ,
N. Simpson  and
S. E. Foster
H. E. J. Miller*
Affiliation:
Department of Psychiatry, Rawnsley Building, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL
N. Simpson
Affiliation:
Department of Psychiatry, Rawnsley Building, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL
S. E. Foster
Affiliation:
Department of Psychiatry, Rawnsley Building, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL
*
∗Correspondence
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Clinical standards were compiled for prescription of psychotropic medication in adults with learning disabilities, and used in a community population for comparisons of current practice in two audit studies 12 months apart. Completing the audit cycle led to improved clinical practice and a rationalisation of prescribing practices. Improvements were achieved on all standards and the methods used to obtain them are discussed.

Type
Audit
Information
Psychiatric Bulletin , Volume 21 , Issue 5 , May 1997 , pp. 286 - 289
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1997 The Royal College of Psychiatrists

References

Clarke, D. J., Kelley, S., Thinn, K., et al (1990) Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings. Journal of Mental Deficiency Research, 34, 385–395.Google ScholarPubMed
Deb, S. & Fraser, W. (1994) The use of psychotropic medication in people with learning disability: towards rational prescribing. Human Psychopharmacology, 9, 259–272.Google Scholar
Gravestock, S. (1996) Regional audit of depot neuroleptic usage in adults with learning disabilities. Psychiatric Bulletin, 20, 289–291.Google Scholar
Harvey, R. J. & Cooray, S. E. (1993) Neuroleptic usage in a community mental handicap unit. Psychiatric Bulletin, 17, 657–660.Google Scholar
Laugharne, R. & Stafford, A. (1996) Access to records and client held records for people with mental illness. Psychiatric Bulletin, 20, 338–341.Google Scholar
Singh, N. N., Guernsey, T. F. & Ellis, C. R. (1992) Drug therapy for persons with developmental disabilities: legislation and litigation. Clinical Psychology Review, 12, 665–679.Google Scholar
World Health Organization (1992) Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD–10). Geneva: WHO.Google Scholar
Wressell, S. E., Tyrer, S. P. & Berney, T. P. (1990) Reduction in antipsychotic drug dosage in mentally handicapped patients. British Journal of Psychiatry, 157, 101–106.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.